speb/financial-data huggingface dataset:
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 94409000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 29097837.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 29129104.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Diluted EPS: 47.91
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.02
INSECTICID.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1394110000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 117099000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 502000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 502000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 3442000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — EBIT: 2022079000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — EBIT: 203857000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — EBITDA: 2377038000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — EBITDA: 298266000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — End Cash Position: 872264000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 175252000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 4149366000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 4149366000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 56547000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -91806000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -4409000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 179309000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 191892000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 191892000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 5145750000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 5145750000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 7060819000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 7060819000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Gross Profit: 6620306000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1288663000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 72711000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 72711000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: 0.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Interest Expense: 155286000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 43196000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 155286000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 43196000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Interest Income: 2611000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 2611000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -168084000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 2608000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Inventory: 7802128000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 7802128000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 13646988000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 13646988000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -864722000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 30745000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 30745000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 137295000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 137295000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Investmentsin Joint Venturesat Cost: 118350000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 118350000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 79986000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 494344000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 494344000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 90040000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 90040000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 187823000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 187823000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 277863000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 277863000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 79986000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -132758000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 118350000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 118350000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 30558000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 30558000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 3615947000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3615947000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Net Debt: 570603000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 570603000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 31816000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Income: 1394110000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Income: 117099000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1394110000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 117099000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1394110000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 117099000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1394110000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 117099000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1394110000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 117099000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1866793000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1394110000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 117099000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Interest Income: -166182000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -43196000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 54799000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 429432000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -52772000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -166182000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -43196000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Net PPE: 4948965000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 4948965000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -925571000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 482204000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 12012229000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 12012229000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 85289000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 85289000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30558000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30558000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 96685000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 96685000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2283552000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 298266000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Normalized Income: 1324295206.68
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 117099000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1002464000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Operating Income: 2031956000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Operating Income: 161550000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Operating Revenue: 21366182000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 4262596000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 29097837.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 29097837.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 753057000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 753057000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1229727000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1229727000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 11913143000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 11913143000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 191892000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 191892000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 264386000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 264386000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 165449000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 196629000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 196629000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 18106000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 47319000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1757102000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 652801000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Payable: 409028000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 409028000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Properties: 50586000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 50586000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 61791000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 61791000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 45651000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 45651000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Other Special Charges: -4565000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Payables: 4802162000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Payables: 4802162000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 41871000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 41871000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 753057000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 753057000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Pretax Income: 1866793000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 160661000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 44692000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1089000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -945917000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 2751759000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 2751759000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 14745876000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2973933000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 354959000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 94409000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 27890000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 27890000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -132758000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: 0.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Research And Development: 105375000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 502000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 502000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 11791333000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 11791333000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 55888000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 20346000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 557043000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 736352000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Share Issued: 29097837.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 29097837.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Special Income Charges: 4280000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 12204121000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12204121000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 12012229000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 12012229000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 23671206.68
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Tax Provision: 472683000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 43562000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
INSECTICID.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -560919000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Assets: 20001800000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 20001800000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 12391944000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 12391944000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1570504000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1570504000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 12204121000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 12204121000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Total Expenses: 19334226000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4101046000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 7797679000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7797679000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 5523976000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5523976000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 393710000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 393710000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 13507000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 93486000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 93486000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Work In Process: 636617000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 636617000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Working Capital: 7073855000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 7073855000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Write Off: 285000.00
INSG income_statement (annual, 2021-12-31) — Amortization: 2092000.00
INSG income_statement (annual, 2021-12-31) — Amortization Of Intangibles Income Statement: 2092000.00
INSG income_statement (annual, 2021-12-31) — Basic Average Shares: 10324630.00
INSG income_statement (annual, 2021-12-31) — Basic EPS: -5.10
INSG balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 0.00
INSG cash_flow (annual, 2021-12-31) — Common Stock Issuance: 29370000.00
INSG balance_sheet (annual, 2021-12-31) — Current Debt: 370000.00
INSG balance_sheet (annual, 2021-12-31) — Current Provisions: 473000.00
INSG income_statement (annual, 2021-12-31) — Diluted Average Shares: 10324630.00
INSG income_statement (annual, 2021-12-31) — Diluted EPS: -5.10
INSG cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -3826000.00
INSG cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -5262000.00
INSG income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 5262000.00
INSG cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 29370000.00
INSG balance_sheet (annual, 2021-12-31) — Land And Improvements: 0.00
INSG balance_sheet (annual, 2021-12-31) — Line Of Credit: 370000.00
INSG cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
INSG balance_sheet (annual, 2021-12-31) — Minority Interest: 0.00
INSG income_statement (annual, 2021-12-31) — Minority Interests: -214000.00
INSG cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 33573000.00
INSG cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 29370000.00
INSG cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
INSG cash_flow (annual, 2021-12-31) — Operating Gains Losses: -9088000.00
INSG balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 323000.00
INSG income_statement (annual, 2021-12-31) — Other Special Charges: 432000.00
INSG cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
INSG cash_flow (annual, 2021-12-31) — Preferred Stock Payments: 0.00
INSG balance_sheet (annual, 2021-12-31) — Prepaid Assets: 2292000.00
INSG cash_flow (annual, 2021-12-31) — Purchase Of Business: -116000.00
INSG cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
INSG balance_sheet (annual, 2021-12-31) — Restricted Cash: 3338000.00
INSG cash_flow (annual, 2021-12-31) — Sale Of Business: 33689000.00
INSG cash_flow (annual, 2021-12-31) — Sale Of PPE: 1338000.00
INSG balance_sheet (annual, 2021-12-31) — Total Tax Payable: 642000.00
INSG income_statement (annual, 2022-12-31) — +Operating Expense: 121813000.00
INSG income_statement (annual, 2022-12-31) — +Total Revenue: 245323000.00
INSG balance_sheet (annual, 2022-12-31) — Accounts Payable: 29018000.00
INSG balance_sheet (annual, 2022-12-31) — Accounts Receivable: 25259000.00
INSG balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -31533000.00
INSG balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 793952000.00
INSG balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -541000.00
INSG income_statement (annual, 2022-12-31) — Amortization: 1749000.00
INSG income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 1749000.00
INSG cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 3014000.00
INSG income_statement (annual, 2022-12-31) — Basic Average Shares: 10726933.00
INSG income_statement (annual, 2022-12-31) — Basic EPS: -6.60
INSG cash_flow (annual, 2022-12-31) — Beginning Cash Position: 49812000.00
INSG cash_flow (annual, 2022-12-31) — Capital Expenditure: -13319000.00
INSG cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -11838000.00
INSG balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 7662000.00
INSG balance_sheet (annual, 2022-12-31) — Capital Stock: 11000.00
INSG balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7143000.00
INSG balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 7143000.00
INSG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 5427000.00
INSG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -13319000.00
INSG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -33289000.00
INSG cash_flow (annual, 2022-12-31) — Change In Account Payable: -26313000.00
INSG cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 3450000.00
INSG cash_flow (annual, 2022-12-31) — Change In Inventory: -3065000.00
INSG cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1555000.00
INSG cash_flow (annual, 2022-12-31) — Change In Payable: -26313000.00
INSG cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -22863000.00
INSG cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 5642000.00
INSG cash_flow (annual, 2022-12-31) — Change In Receivables: 2441000.00
INSG cash_flow (annual, 2022-12-31) — Change In Working Capital: -19400000.00
INSG cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 2441000.00
INSG cash_flow (annual, 2022-12-31) — Changes In Cash: -41181000.00
INSG balance_sheet (annual, 2022-12-31) — Common Stock: 11000.00
INSG balance_sheet (annual, 2022-12-31) — Common Stock Equity: -70118000.00
INSG cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
INSG income_statement (annual, 2022-12-31) — Cost Of Revenue: 178414000.00
INSG balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 13611000.00
INSG balance_sheet (annual, 2022-12-31) — Current Assets: 78356000.00
INSG balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1759000.00
INSG balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1759000.00
INSG balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 7888000.00
INSG balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 7888000.00
INSG balance_sheet (annual, 2022-12-31) — Current Liabilities: 56963000.00
INSG balance_sheet (annual, 2022-12-31) — Current Provisions: 480000.00
INSG cash_flow (annual, 2022-12-31) — Deferred Income Tax: -570000.00
INSG cash_flow (annual, 2022-12-31) — Deferred Tax: -570000.00
INSG cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 27206000.00
INSG income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 24490000.00
INSG cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 27206000.00
INSG income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 24490000.00
INSG income_statement (annual, 2022-12-31) — Diluted Average Shares: 10726933.00
INSG income_statement (annual, 2022-12-31) — Diluted EPS: -6.60
INSG income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -70705000.00
INSG income_statement (annual, 2022-12-31) — EBIT: -59828000.00
INSG income_statement (annual, 2022-12-31) — EBITDA: -32622000.00
INSG cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1488000.00
INSG cash_flow (annual, 2022-12-31) — End Cash Position: 7143000.00
INSG cash_flow (annual, 2022-12-31) — Financing Cash Flow: 5427000.00
INSG balance_sheet (annual, 2022-12-31) — Finished Goods: 31153000.00
INSG cash_flow (annual, 2022-12-31) — Free Cash Flow: -46608000.00
INSG cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -926000.00
INSG cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
INSG income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
INSG balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -6329000.00
INSG income_statement (annual, 2022-12-31) — General And Administrative Expense: 26208000.00
INSG balance_sheet (annual, 2022-12-31) — Goodwill: 21922000.00
INSG balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 63305000.00
INSG balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 25800000.00
INSG balance_sheet (annual, 2022-12-31) — Gross PPE: 48401000.00
INSG income_statement (annual, 2022-12-31) — Gross Profit: 66909000.00
INSG income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 3014000.00
INSG cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 168000.00
INSG income_statement (annual, 2022-12-31) — Interest Expense: 8606000.00
INSG income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 8606000.00
INSG cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 5535000.00
INSG balance_sheet (annual, 2022-12-31) — Interest Payable: 1112000.00
INSG balance_sheet (annual, 2022-12-31) — Inventory: 37976000.00
INSG balance_sheet (annual, 2022-12-31) — Invested Capital: 96160000.00
INSG cash_flow (annual, 2022-12-31) — Investing Cash Flow: -13319000.00
INSG cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
INSG cash_flow (annual, 2022-12-31) — Issuance Of Debt: 7851000.00
INSG balance_sheet (annual, 2022-12-31) — Leases: 772000.00
INSG balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
INSG balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 5903000.00
INSG balance_sheet (annual, 2022-12-31) — Long Term Debt: 166278000.00
INSG balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 172181000.00
INSG cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 12351000.00
INSG cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -62000.00
INSG balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5936000.00
INSG income_statement (annual, 2022-12-31) — Minority Interests: 0.00
INSG cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
INSG cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
INSG balance_sheet (annual, 2022-12-31) — Net Debt: 159135000.00
INSG income_statement (annual, 2022-12-31) — Net Income: -67969000.00
INSG income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -70705000.00
INSG income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -67969000.00
INSG income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -67969000.00
INSG income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -67969000.00
INSG cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -67969000.00
INSG income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -67969000.00
INSG income_statement (annual, 2022-12-31) — Net Interest Income: -8606000.00
INSG cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 7220000.00
INSG cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -62000.00
INSG income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -8606000.00
INSG cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -2693000.00
INSG balance_sheet (annual, 2022-12-31) — Net PPE: 16868000.00
INSG cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1481000.00
INSG cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
INSG cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 7282000.00
INSG balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -133423000.00
INSG balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 323000.00
INSG balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 323000.00
INSG income_statement (annual, 2022-12-31) — Normalized EBITDA: -29608000.00
INSG income_statement (annual, 2022-12-31) — Normalized Income: -64975479.73
INSG cash_flow (annual, 2022-12-31) — Operating Cash Flow: -33289000.00
INSG cash_flow (annual, 2022-12-31) — Operating Gains Losses: -926000.00
INSG income_statement (annual, 2022-12-31) — Operating Income: -54904000.00
INSG income_statement (annual, 2022-12-31) — Operating Revenue: 245323000.00
INSG balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 10846815.00
INSG balance_sheet (annual, 2022-12-31) — Other Current Assets: 2379000.00
INSG balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 4238000.00
INSG balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -6329000.00
INSG income_statement (annual, 2022-12-31) — Other Gand A: 26208000.00
INSG income_statement (annual, 2022-12-31) — Other Income Expense: -4924000.00
INSG balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 41383000.00
INSG cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4678000.00
INSG balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1420000.00
INSG balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 600000.00
INSG income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1910000.00
INSG balance_sheet (annual, 2022-12-31) — Other Properties: 41693000.00
INSG balance_sheet (annual, 2022-12-31) — Other Receivables: 5599000.00
INSG income_statement (annual, 2022-12-31) — Other Special Charges: 450000.00
INSG balance_sheet (annual, 2022-12-31) — Payables: 29467000.00
INSG balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 43078000.00
INSG balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
INSG income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 2736000.00
INSG cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
INSG cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
INSG balance_sheet (annual, 2022-12-31) — Prepaid Assets: 841000.00
INSG income_statement (annual, 2022-12-31) — Pretax Income: -68434000.00
INSG cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 900000.00
INSG balance_sheet (annual, 2022-12-31) — Properties: 0.00
INSG cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 2803000.00
INSG cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
INSG cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1481000.00
INSG balance_sheet (annual, 2022-12-31) — Raw Materials: 6823000.00
INSG balance_sheet (annual, 2022-12-31) — Receivables: 30858000.00
INSG income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 175698000.00
INSG income_statement (annual, 2022-12-31) — Reconciled Depreciation: 27206000.00
INSG cash_flow (annual, 2022-12-31) — Repayment Of Debt: -631000.00
INSG cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
INSG income_statement (annual, 2022-12-31) — Research And Development: 38290000.00
INSG balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
INSG balance_sheet (annual, 2022-12-31) — Retained Earnings: -857752000.00
INSG cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
INSG cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
INSG income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 32825000.00
INSG income_statement (annual, 2022-12-31) — Selling General And Administration: 59033000.00
INSG balance_sheet (annual, 2022-12-31) — Share Issued: 10846815.00
INSG cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 7851000.00
INSG cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -569000.00
INSG income_statement (annual, 2022-12-31) — Special Income Charges: -3014000.00
INSG cash_flow (annual, 2022-12-31) — Stock Based Compensation: 17875000.00
INSG balance_sheet (annual, 2022-12-31) — Stockholders Equity: -70118000.00
INSG balance_sheet (annual, 2022-12-31) — Tangible Book Value: -133423000.00
INSG income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -20479.73
INSG income_statement (annual, 2022-12-31) — Tax Provision: -465000.00
INSG income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.01
INSG balance_sheet (annual, 2022-12-31) — Total Assets: 159949000.00
INSG balance_sheet (annual, 2022-12-31) — Total Capitalization: 96160000.00
INSG balance_sheet (annual, 2022-12-31) — Total Debt: 173940000.00
INSG balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -70118000.00
INSG income_statement (annual, 2022-12-31) — Total Expenses: 300227000.00
INSG balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 230067000.00
INSG balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 81593000.00
INSG balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 173104000.00
INSG income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -57918000.00
INSG balance_sheet (annual, 2022-12-31) — Total Tax Payable: 449000.00
INSG income_statement (annual, 2022-12-31) — Total Unusual Items: -3014000.00
INSG income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -3014000.00
INSG balance_sheet (annual, 2022-12-31) — Working Capital: 21393000.00
INSG income_statement (annual, 2023-12-31) — +Operating Expense: 70618000.00
INSG income_statement (annual, 2023-12-31) — +Total Revenue: 167286000.00
INSG balance_sheet (annual, 2023-12-31) — Accounts Payable: 23408000.00
INSG balance_sheet (annual, 2023-12-31) — Accounts Receivable: 18202000.00
INSG balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -27513000.00
INSG balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 810138000.00
INSG balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -617000.00
INSG cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 2859000.00
INSG balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 12123000.00
INSG income_statement (annual, 2023-12-31) — Basic Average Shares: 11372069.00
INSG income_statement (annual, 2023-12-31) — Basic EPS: -4.32
INSG cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3241000.00
INSG cash_flow (annual, 2023-12-31) — Capital Expenditure: -8336000.00
INSG cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -8112000.00
INSG balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 5198000.00
INSG balance_sheet (annual, 2023-12-31) — Capital Stock: 12000.00
INSG balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2409000.00
INSG balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2409000.00
INSG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2211000.00
INSG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -8336000.00
INSG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 3750000.00
INSG cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 0.00
INSG cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: -1833000.00
INSG cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: 2207000.00
INSG cash_flow (annual, 2023-12-31) — Change In Account Payable: -802000.00
INSG cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 235000.00
INSG cash_flow (annual, 2023-12-31) — Change In Inventory: 4272000.00
INSG cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -1272000.00
INSG cash_flow (annual, 2023-12-31) — Change In Payable: -802000.00
INSG cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -567000.00
INSG cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 1933000.00
INSG cash_flow (annual, 2023-12-31) — Change In Receivables: 3068000.00
INSG cash_flow (annual, 2023-12-31) — Change In Working Capital: 7434000.00
INSG cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 3068000.00
INSG cash_flow (annual, 2023-12-31) — Changes In Cash: -2001000.00
INSG balance_sheet (annual, 2023-12-31) — Common Stock: 12000.00
INSG balance_sheet (annual, 2023-12-31) — Common Stock Equity: -102105000.00
INSG cash_flow (annual, 2023-12-31) — Common Stock Issuance: 6057000.00
INSG income_statement (annual, 2023-12-31) — Cost Of Revenue: 131510000.00
INSG balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 13028000.00
INSG balance_sheet (annual, 2023-12-31) — Current Assets: 58226000.00
INSG balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1226000.00
INSG balance_sheet (annual, 2023-12-31) — Current Debt: 4094000.00
INSG balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5320000.00
INSG balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 2717000.00
INSG balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 2717000.00
INSG balance_sheet (annual, 2023-12-31) — Current Liabilities: 55911000.00
INSG cash_flow (annual, 2023-12-31) — Deferred Income Tax: 9000.00
INSG cash_flow (annual, 2023-12-31) — Deferred Tax: 9000.00
INSG cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 18709000.00
INSG income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 18408000.00
INSG cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 18709000.00
INSG income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 18408000.00
INSG income_statement (annual, 2023-12-31) — Diluted Average Shares: 11372069.00
INSG income_statement (annual, 2023-12-31) — Diluted EPS: -4.32
INSG income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -49176000.00
INSG income_statement (annual, 2023-12-31) — EBIT: -35887000.00
INSG income_statement (annual, 2023-12-31) — EBITDA: -17178000.00
INSG cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1169000.00
INSG cash_flow (annual, 2023-12-31) — End Cash Position: 2409000.00
INSG cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2211000.00
INSG balance_sheet (annual, 2023-12-31) — Finished Goods: 18939000.00
INSG cash_flow (annual, 2023-12-31) — Free Cash Flow: -2379000.00
INSG balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -5327000.00
INSG income_statement (annual, 2023-12-31) — General And Administrative Expense: 15853000.00
INSG balance_sheet (annual, 2023-12-31) — Goodwill: 3949000.00
INSG balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 29667000.00
INSG balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 18819000.00
INSG balance_sheet (annual, 2023-12-31) — Gross PPE: 33924000.00
INSG income_statement (annual, 2023-12-31) — Gross Profit: 35776000.00
INSG income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 1115000.00
INSG cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 142000.00
INSG income_statement (annual, 2023-12-31) — Interest Expense: 9086000.00
INSG income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 9086000.00
INSG cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 6013000.00
INSG balance_sheet (annual, 2023-12-31) — Interest Payable: 1038000.00
INSG balance_sheet (annual, 2023-12-31) — Inventory: 20555000.00
INSG balance_sheet (annual, 2023-12-31) — Invested Capital: 61901000.00
INSG cash_flow (annual, 2023-12-31) — Investing Cash Flow: -10169000.00
INSG cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 6057000.00
INSG cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
INSG balance_sheet (annual, 2023-12-31) — Leases: 767000.00
INSG balance_sheet (annual, 2023-12-31) — Liabilities Heldfor Sale Non Current: 1644000.00
INSG balance_sheet (annual, 2023-12-31) — Line Of Credit: 4094000.00
INSG balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 3972000.00
INSG balance_sheet (annual, 2023-12-31) — Long Term Debt: 159912000.00
INSG balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 163884000.00
INSG cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
INSG balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 4382000.00
INSG cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 6057000.00
INSG balance_sheet (annual, 2023-12-31) — Net Debt: 161597000.00
INSG income_statement (annual, 2023-12-31) — Net Income: -46185000.00
INSG income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -49176000.00
INSG income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -45016000.00
INSG income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -1169000.00
INSG income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -46185000.00
INSG income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -45016000.00
INSG cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -46185000.00
INSG income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -46185000.00
INSG income_statement (annual, 2023-12-31) — Net Interest Income: -9086000.00
INSG cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -3943000.00
INSG cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
INSG income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -9086000.00
INSG balance_sheet (annual, 2023-12-31) — Net PPE: 6411000.00
INSG cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -224000.00
INSG cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -3943000.00
INSG balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -131772000.00
INSG balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 1816000.00
INSG balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 1704000.00
INSG balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 112000.00
INSG income_statement (annual, 2023-12-31) — Normalized EBITDA: -16063000.00
INSG income_statement (annual, 2023-12-31) — Normalized Income: -44135150.00
INSG cash_flow (annual, 2023-12-31) — Operating Cash Flow: 5957000.00
INSG income_statement (annual, 2023-12-31) — Operating Income: -34842000.00
INSG income_statement (annual, 2023-12-31) — Operating Revenue: 167286000.00
INSG balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 11878557.00
INSG balance_sheet (annual, 2023-12-31) — Other Current Assets: 1164000.00
INSG balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 11438000.00
INSG balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -5327000.00
INSG income_statement (annual, 2023-12-31) — Other Gand A: 15853000.00
INSG income_statement (annual, 2023-12-31) — Other Income Expense: -1045000.00
INSG balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 25718000.00
INSG cash_flow (annual, 2023-12-31) — Other Non Cash Items: 4160000.00
INSG balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 27493000.00
INSG balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 647000.00
INSG income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 70000.00
INSG balance_sheet (annual, 2023-12-31) — Other Properties: 28775000.00
INSG balance_sheet (annual, 2023-12-31) — Other Receivables: 3773000.00
INSG balance_sheet (annual, 2023-12-31) — Payables: 23408000.00
INSG balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 36436000.00
INSG balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
INSG income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 2991000.00
INSG income_statement (annual, 2023-12-31) — Pretax Income: -44973000.00
INSG cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 97000.00
INSG balance_sheet (annual, 2023-12-31) — Properties: 0.00
INSG cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 9793000.00
INSG cash_flow (annual, 2023-12-31) — Purchase Of PPE: -224000.00
INSG balance_sheet (annual, 2023-12-31) — Raw Materials: 1616000.00
INSG balance_sheet (annual, 2023-12-31) — Receivables: 21975000.00
INSG income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 131209000.00
INSG income_statement (annual, 2023-12-31) — Reconciled Depreciation: 18709000.00
INSG cash_flow (annual, 2023-12-31) — Repayment Of Debt: -3943000.00
INSG income_statement (annual, 2023-12-31) — Research And Development: 19725000.00
INSG balance_sheet (annual, 2023-12-31) — Retained Earnings: -906928000.00
INSG income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 16632000.00
INSG income_statement (annual, 2023-12-31) — Selling General And Administration: 32485000.00
INSG balance_sheet (annual, 2023-12-31) — Share Issued: 11878557.00
INSG cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
INSG cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -3943000.00
INSG income_statement (annual, 2023-12-31) — Special Income Charges: -1115000.00
INSG cash_flow (annual, 2023-12-31) — Stock Based Compensation: 6971000.00
INSG balance_sheet (annual, 2023-12-31) — Stockholders Equity: -102105000.00
INSG balance_sheet (annual, 2023-12-31) — Tangible Book Value: -131772000.00
INSG income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -234150.00
INSG income_statement (annual, 2023-12-31) — Tax Provision: 43000.00
INSG income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
INSG balance_sheet (annual, 2023-12-31) — Total Assets: 121797000.00
INSG balance_sheet (annual, 2023-12-31) — Total Capitalization: 57807000.00
INSG balance_sheet (annual, 2023-12-31) — Total Debt: 169204000.00
INSG balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -102105000.00
INSG income_statement (annual, 2023-12-31) — Total Expenses: 202128000.00
INSG balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 223902000.00